Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective

Area of Science:

• Neuroscience
• Pharmacology
• Clinical Medicine

Background:

• Neuroleptic malignant syndrome (NMS) is a rare, life-threatening adverse reaction to antipsychotic medications.
• Key symptoms include hyperpyrexia, muscle rigidity, autonomic instability, and altered mental status.

Purpose of the Study:

• To review current understanding of NMS causes and treatments.
• To analyze epidemiological data on NMS incidence, including drug-specific and polypharmacy cases.
• To discuss NMS pathogenesis, clinical presentation, diagnosis, and therapeutic interventions.

Main Methods:

• Literature review of past and current developments in NMS research.
• Analysis of epidemiological data from the Canada Vigilance Adverse Reaction Online database (1965-2012).
• Summary of established risk factors, leading etiopathological theories, and clinical perspectives.

Main Results:

• Evaluation of NMS epidemiological incidence and new data on drug-specific and polypharmacy instances.
• Summary of risk factors, including pharmacological and environmental influences.
• Discussion of NMS pathogenesis, including dopamine receptor blockade and muscle toxicity.

Conclusions:

• Comprehensive overview of NMS, encompassing its etiology, clinical features, and diagnostic challenges.
• Outline of current pharmacological and non-pharmacological treatment strategies for NMS.
• Emphasis on the importance of understanding NMS for safe antipsychotic drug use.